Yashwantrao Bhonsale College of Pharmacy, Charathe, Sawantwadi tal- Sawantwadi dist. - Sindhudurg 416510.
Pathological conditions refer to abnormal or diseased state that effect on body’s organ, tissues,or systems. These condition causes due to various factors such as Genetic mutation, Infection ,Environmental factor, Autonomic Disorder .There are so many conditions like, Cardiovascilar condition, Neurological conditions, Immunological conditions. Migraine is Neurological disorder.It is characterised by recurrent episode of Headache, typically one sided, pulsating and moderate to severe intensity often accompanied by sensitivity to light ,sound and nausea. Types of migraine like Migraine with aura, Migraine without aura ,Chronic and Episodic migraine. There are Triptans - Sumatriptan, Rizatriptan are chemicals as well as Ginger, Peppermint oil, Lavendor oil ,Turmeric are Herbal treatments are used . Herbals are easily available .This review provides briefly about herbal use for the migraine treatment .It also provides various extraction and analysis procedure of herbals used in migraine. Formulated the oral dissolving film on migraine disease. Oral dissolving film gives effect best than oral disintegrating tablet. Evaluation of oral dissolving film.
What are pathological conditions:
Pathological conditions refer to any disease, disorder, or abnormality that disrupts the normal functioning of tissues, organs, or systems within the body.
These conditions arise from a variety of causes, including genetic mutations, infections, injuries, environmental factors, and degenerative processes. Pathological changes can affect the structure and function of cells and tissues, leading to symptoms and complications that may impair a person's quality of life.
Examples of pathological conditions include cancer, where cells grow uncontrollably; cardiovascular diseases, which disrupt the flow of blood; and autoimmune disorders, where the immune system mistakenly attacks healthy tissues.
Diagnosis and treatment depend on the specific condition and its underlying causes, with therapies aimed at managing symptoms, correcting dysfunction, or halting disease progression.
Pathological conditions can be classified into several types based on their causes, nature, and affected systems. Here are some major types:
What is Headache
Headaches is a most common neurological condition and are often linked to disruptions in various parts of the brain, particularly in the cerebral cortex, which processes sensory information like pain, touch, and temperature. The brainstem, which regulates autonomic functions such as breathing and heartbeat, also plays a role in headache related symptoms. Additionally, changes in blood flow through the carotid arteries can impact the brain’s overall function, contributing to the onset of headaches. These connections highlight how different brain regions and their functions can influence the experience of headaches.
Fig.4 Types of Headaches
Headache
Pathological Condition -Migraine
What is Migraine :
A migraine is a type of headache. It may occur with symptoms such as nausea, vomiting, or sensitivity to light and sound. In most people, a throbbing pain is felt only on one side of the head. Migraine is considered a neurological disorder, a type of pathological condition that affects the nervous system. It involves recurring headaches, often accompanied by symptoms like nausea, sensitivity to light and sound, and visual disturbances (aura). While the exact cause of migraines is not fully understood, they are thought to involve abnormal brain activity, including changes in blood flow and the release of certain chemicals. Migraines are often triggered by factors such as stress, hormonal changes, certain foods, and environmental stimuli. Neurological disorders, like migraines, are characterized by disruptions in normal brain and nerve function.
Causes:
A migraine headache is caused by abnormal brain activity. This activity can be triggered by many things. But the exact chain of events remains unclear. Most medical experts believe the attack begins in the brain and involves nerve pathways and chemicals. The changes affect blood flow in the brain and surrounding tissues. Migraine headaches tend to first appear between the ages of 10 and 45. Sometimes, they begin earlier or later. Migraines may run in families. Migraines occur more often in women than men.
Some women, but not all, have fewer migraines when they are pregnant.
Migraine attacks may be triggered by any of the following;
Migraines can be classified into the following types:
A migraine without aura: This subtype involves recurrent headache attacks lasting 4 to 72 hours. The pain is typically unilateral, pulsating in quality, moderate-to-severe in intensity, aggravated by physical activity, and associated with nausea, light (photophobia), and sound sensitivity (phonophobia).
Migraine with aura: This subtype features recurrent, fully reversible attacks lasting minutes, typically presenting with 1 or more unilateral symptoms such as visual, sensory, speech and language, motor, brainstem, or retinal disturbances, usually followed by headache and other migraine symptoms.
Chronic migraine: This is defined as a headache that occurs on 15 or more days in a month for more than 3 months, with migraine features present on at least 8 or more days in a month.
Probable migraine: This is a symptomatic migraine attack that lacks 1 of the features required to fulfill the criteria for 1 of the above and does not meet the criteria for another type of headache.
Symptoms :
There are two main types of migraines:
An aura is a group of nervous system (neurologic) symptoms. These symptoms are considered a warning sign that a migraine is coming. Most often, the vision is affected and can include any or all of the following:
Other nervous system symptoms include yawning, difficulty concentrating, nausea , trouble finding the right words, dizziness, weakness, numbness, and tingling. Some of these symptoms are much less common with migraine headaches. If you have any of these symptoms, your provider will likely order tests to find the cause. An aura often occurs 10 to 15 minutes before the headache, but can occur just a few minutes to 24 hours before. A headache does not always follow an aura.
The headaches usually:
Other symptoms that may occur with the headache include:
Symptoms may linger, even after the migraine goes away. This is called a migraine hangover.
Symptoms can include:
Exams and Tests:
Your provider can diagnose migraine headache by asking about your symptoms and family history of migraines. A complete physical and neurological exam will be done to determine if your headaches are due to muscle tension, sinus problems, or a brain disorder. There is no specific test to prove that your headache is actually a migraine. In most cases, no special tests are needed. Your provider may order a brain CT or MRI scan if you have never had one before.
Treatment:
There is no specific cure for migraine headaches. The goal is to treat your migraine symptoms right away and to prevent symptoms by avoiding or changing your triggers. A key step is learning how to manage your migraines at home. A headache diary can help you identify your headache triggers. Then you and your provider can plan how to avoid these triggers.
Lifestyle changes include:
If you have frequent migraines, your provider may prescribe medicine to reduce the number of attacks. You need to take the medicine every day for it to be effective. Medicines may include:
Some people find relief with minerals and vitamins. Check with your provider to see if riboflavin or magnesium is right for you. Some of these medicines may not be safe for a pregnant or breastfeeding woman to take.
Mechanism Of Antimigraine Drug;
Oral Dissolving Film
Developing formulations for children has been a challenging task.
The concept of oral dissolving film
The Advantages of fast dissolving films
Salient features of fast dissolving oral films
Disadvantages of ODF
Classification of oral films
There are three types of oral films. They are:
MATERIALS AND METHOD
Technologies used in the manufacture of mouth dissolving films:
1. Solvent casting
2. Semisolid casting
3. Hot melt extrusion
4. Solid dispersion extrusion
5. Rolling
Solvent Casting Method
In this method, the water soluble polymers are dissolved in suitable solvent and the drug along with other excipients is dissolved in suitable solvent. Then both solutions are mixed and stirred and finally casted into the petri plate and dried.
ADVANTAGES
DISADVANTAGES
Difference Between Oral Fast Dissolving Film and Oral Fast Dissolving Tablet
Orally Fast Dissolving Films |
Orally Fast Dissolving Tablet |
Larger surface area gives greator dissolution. |
Less surface area gives less dissolution than odf. |
These are flexible and durable . |
These are brittle and less durable than odf. |
Low doses incorporated . |
High dose incorporated. |
Thikness 50 to 500 mm. |
Thikness like conventional tablet. |
Patient compliance is more . |
Patient compliance is les than odf. |
Treating An Attack
Hydration with fluids is often helpful, with or without the use of medicines. Other medicines are taken at the first sign of a migraine attack. Over-the-counter (OTC) pain medicines, such as acetaminophen, naproxen, ibuprofen, or aspirin are often helpful when your migraine is mild.
Synthetic drugs used in the treatment of migraine:
A) Selective 5-HT agonist
Ergot alkaloids
C)Others
Objectives
1) To formulate oral dissolving film by use of natural drug .
2)The aim of presented work is to formulate as well as evaluate the oral dissolving film that is –
3)Formula focus on to treat and prevent migraine problem .
4)Formulation prepared has no side effect beacause natural drug is use.
5)Formulation is evaluated for its physical and chemical parameter.
Plan Of Work
Master Formula
Sr.NO |
Ingredient |
Qty |
Property |
1 |
Ginger |
0.25 gm |
API |
2 |
HPMC |
1.45 gm |
Polymer |
3 |
PEG |
1ml |
Plastisizer |
4 |
Citric acid |
0.03 mg |
Antioxidant |
5 |
Sucrose |
0.04 |
Sweetner |
6 |
Menthol |
0.1 mg |
Flavorant |
7 |
Amaranth |
0.01 |
Colorant |
Formulation Of Oral Dissolving Film
? Herbal drugs used in treatment of migraine
Advantages of herbal preparation over allopathy medicines
Disadvantages Of Herbal Medicines
Lack of standardization
Drug Profile
Synonyms : Zingiber, Zingiberis, Sunthi.
Family : Zingiberaceae
Biological Source : Ginger consists of whole or cut, dried scrapped or unscrapped rhizomes of Zingiber officinale Roscoe, family Zingiberaceae. It contains not less than 0.8 per cent of total gingerols on dried basis
Chemical constituents : ginger consists of volatile oil ( 1 - 4 %),starch (40 – 60 %) ,fat (10 %), fiber (5%), inorganic material (6%), residual moisture (10%), and acrid resinous matter (5-10%), ginger oil is constituted of monoterpene hydrocarbons , sesquiterpene hydrocarbons, oxygenated mono and sesqueterpenes and phenyl propanoids.
Sesquiterpenes hydrocarbon content of all types of ginger oil from different countries is found to be same and includes α- zingiberene , β- bisabolene, αfarnesene, β-sesquiphellandrene and α-curcumene. Aroma and flavour are the main characters of ginger. Aroma is due to fragrant principles of volatile oil while the flavour, pungency and pharmacological action is exerted by phenolic ketones of oleo-resin. Various components of volatile oil like isometric terpenic aldehydes like geranial and citral, which cause the delicate and lemony aroma. Few sesquiterpene oil hydrocarbons ale believed to exert spicy note Phenolic ketones of oleo resin include gingerols like shogaols, zingerone, paradols, gingediols, hexahydrocurcumin and also omethyl ethers of these compounds.
Uses: Ginger is used as a stomachic, an aromatic, a carminative, stimulant and flavouring agert. Ginger oil is used in mouth washes, ginger beverages and liquors, Ginger powder has been reported to be effective in motion sickness. It has been suggested tha adsorbent, aromatic and carminative properties of ginger on G. I. tract cause adsorption of toxins and acid enhanced gastric motility. These may have probably blocking effects of G. I. reactions and nausea. Z. officinale (Methanolic extract) has molluscicidal effects, possessing efficacy to control te parasitic infection viz. schistosomiasis. U.S. Food and Drug administration has included ginger s product that is generally regarded as safe (GRAS).
Methodology & Requirement
Requirements:
Ingredient |
Part of plant |
Zingiber officinale |
Rhizome |
Method of Extraction of Ginger:
Isolation and standardization of gingerol from ginger
Identification:
TLC method:
Preparation of plate:
Prepare a suspension of coating and spread a uniform layer of suspension. 0.25 to 0.30 mm thick on a flat glass plate of 20cm long. Dry in air and heat at 100 to 105°C and concentrate to 10ml.
Mobile phase: - Hexane: Diethyl ether (30:70v/v)
Test solution: 1gm of coarsely powder substance with 25ml Methanol for 15 mins. Cool and filter. wash the residue with 10ml of methanol, combine all the filtrate and concentrate to 10ml.
Reference solution: -0.5gm of powder with 5ml methanol for 15 mins. Cool and filter. Apply to the plate 10ul bands of 10mm by 2mm.
ii. UV method Development: Calibrate curve of rhizome extract in methanol at wavelength of 281.40nm.
Evaluation of Extract
Alkaloid test:
5g each of the ginger extracts and 5ml of honey was stirred with 5ml of 1% aqueous hydrochloric acid on a steam bath. Iml of the filtrate was treated with few drops of Draggendoff's reagent. Blue black turbidity serves as preliminary evidence of alkaloids.
Saponins test:
5g each of the extracts and 5ml of honey was shaken with distilled water in a test tube. Frothing which persists on warning was taken as preliminary evidence of the presence of saponins.
Tannins test:
5g each of the extracts and 5ml of honey was stirred with 100ml distilled water and filtered. Ferric chloride reagent was added to the filtrate. A blueblack or blue green precipitate determines the presence of tannins.
Flavonoids test:
5ml of diluted ammonia solution was added to aqueous filtrate of the test samples followed by the addition of concentrated sulphuric acid (H?SO?). A yellow coloration observation determines the presence of flavonoid.
Terpenoid (Salkowski test):
To 0.5 g of the extract, 2 ml of chloroform was added: Conc. Sulphuric acid (H?SO?) (3 ml) was carefully added to form a layer. A reddish brown coloration of the interface indicates the presence of terpenoid.
Trials And Errors
Formulation |
Thickness (µm) (Mean ± S.D) |
Weight Variation (mg cm?²) (Mean ± S.D) |
Folding Endurance |
Drug Content (%) |
F1 |
204 ± 0.071 |
248 ± 1.40 |
167 ± 02 |
92.65 ± 3.08 |
F2 |
218 ± 0.002 |
236 ± 1.36 |
180 ± 03 |
91.96 ± 3.16 |
F3 |
194 ± 0.012 |
255 ± 1.05 |
151 ± 02 |
92.54 ± 2.96 |
F4 |
200 ± 0.031 |
245 ± 1.42 |
175 ± 02 |
91.04 ± 3.25 |
F5 |
201 ± 0.098 |
253 ± 1.01 |
153 ± 03 |
93.05 ± 3.98 |
F6 |
210 ± 0.051 |
239 ± 1.85 |
159 ± 03 |
93.76 ± 2.85 |
F7 |
199 ± 0.042 |
241 ± 1.35 |
155 ± 02 |
93.27 ± 3.15 |
Formulation |
Tensile strength (g / cm?²) |
% flatness |
Surface pH |
Disintegration test |
F1 |
202.11 ± 0.112 |
99.7 ± 1 |
5.54 |
120sec |
F2 |
189.54 ± 0.096 |
100 ± 1 |
5.60 |
100sec |
F3 |
196.11 ± 0.089 |
97 ± 1 |
6.00 |
90sec |
F4 |
184.54 ± 0.096 |
99.8 ± 3 |
6.20 |
30sec |
F5 |
199.43 ± 0.108 |
99.7 ± 2 |
5.89 |
40sec |
F6 |
179.15 ± 0.095 |
99 ± 3 |
6.00 |
35sec |
F7 |
192.78 ± 0.108 |
100 ± 4 |
6.50 |
31sec |
Evaluation Test Process of Oral Dissolving Film
1. Appearance
The formulated films should be checked for their appearance. Film should be checked
visually for their appearance.
2. Thickness of films
The thickness of the film was measured by micrometre screw gauge at three different places and average of three values was calculated. This is essential to ascertain uniformity in the thickness of the film which is directly related to the accuracy of dose in the film.
3. Weight of films / weight variation
Oral fast dissolving films were weighed on analytical balance and average weight can be determined for each film. It is desirable that films should have nearly constant weight. It is useful to ensure that a film contains the proper amount of excipients and API.
4.Folding endurance
Folding endurance of the film is essential to study the elasticity of the film during storage and handling. The folding endurance of the film films was determined by repeatedly folding one film at the same place till it broke. This is considered to reveal good film properties. A film (2 X 2 cm) was cut evenly and repeatedly folded at the same place till it breaks. The number of times the film could be folded at the same place without breaking gave the exact value of folding endurance. All determination were performed in triplicate.
5.pH value
The pH value was determined by dissolving one oral film in 10 ml distilled water and measuring the pH of the obtained solution. All determinations were performed in triplicate. It is necessary that strip should have nearly uniform pH value.
6.Tensile strength
Tensile strength is the maximum stress applied to a point at which the film specimen breaks. This test is basically performed to measure the mechanical strength of the films. It can be calculated from applied load at cleavage divided by the film crosssectional area given in the equation below:
Tensile strength = (load at failure / strip thickness ×strip width) × 100
7.Flatness study
Flatness study was conducted to appraise that the prepared transdermal film possess a smooth surface and shall not constrict with time. From each film the preparing strips were cut out, one from the centre and two from the either side. The variation in the length and the length of each strip was measured because of non- uniform in flatness which was measured by determining %of constriction, considering 0% constriction is equivalent to 100% flatness.
% of constriction= (l 1 − l 2)/l 1 × 100 Where, l1 = initial length of each strip and l2 = final length of each strip.
8. Disintegration time
It was determined visually in a glass beaker filled with 25 ml distilled water with swirling every 10seconds. The time at which film started to break or disintegrate was recorded as the in-vitro disintegration time.
9.Drug content
Film is cut into 1*1/2*2 dissolve in phosphate buffer ph 6.8 in 100ml volumetric flask.1ml withdrawn from this and made 10ml check absorbance on uv 285 nm. procedure do for all trial batch.
Confirmation of drug
10. UV-VIS Spectrophotometric method
Methanol was selected for preparation of calibration curve 100mg of crude extract was dissolved in methanol and diluted upto 100ml to get concentration of 1000ppm which is treated as stock solution. This stock solution was diluted further to get different concentrations. Resultant solutions were scanned for λmax in the range of 200?400 nm using UVspectrophotometer.
RESULT AND DISCUSSION
1) Physical Appearance
All the patches were found to be smooth in texture and of good appearance.
Parameter |
Standard |
Observed |
Texture |
Transparent ,clean ,clear |
Transparent ,clean ,clear |
Colour |
Uniform thickness,pink colour,thin easily remove but some are sticky |
Uniform thickness,pink colour,thin easily remove but some are sticky |
Homogeneity
|
Good texture at all edges |
Good texture at all edges |
Solubility
Solvent |
Solubility |
Water |
Soluble |
Acetone |
Insoluble |
Ethanol |
Soluble |
Methanol |
Soluble |
2) Weight variation and thickness
The weight variations of the patches were in the range of 232 mg cm?² to 268 mg for cm? ² 9 formulations difference in weight variation was due to addition of polymer in different ratios which influence weight of film. Thickness of the film for 7 different polymer varied from 194 µm to 218 µm. The maximum difference between the thicknesses of film was 0.09 mm, the weight variation and thickness is given in the which indicates that all the prepared film were of nearly uniform thickness.
3) Folding Endurance
Folding endurance of the film was determined by repeatedly folding one film at the same place till it broke or folded up to 180 times manually, which was considered satisfactory to reveal good film properties. The number of folding required to break or crack the film was taken as the folding endurance.That is, they have sufficient flexibility and good mechanical strength. They indicated that all the film can withstand to rupture and would maintain their integrity with general folding when used. The folding endurance values lie in between 151 and 180 and was measured manually. The prepared films shows good tensile strength and there was no sign of cracking in prepared film.
4) Surface pH
The surface pH of the film was determined to check whether the film irritates the skin. The pH of all the film was found to be in the range of that of the normal pH of skin 5-7. Hence no irritation to the skin was expected from these prepared films .
5)Tensile Strength
The results obtained from the tensile strength test of the film showed that formulations containing HPMC had the highest tensile strength and was in the range of 202.11 g/ cm?² .For film strong strength is preffered .
6) Drug Content
The drug content varied due to polymers which were added in different concentrations. As the polymer concentration increases, the bond formation between the drug molecules and polymer molecules increases which will retard the drug release. Drug content of all batches were well within the range between 91.04 and 94.05 ± 2.98 %
7) flatness
Flatness is achieved .Film was properly distributrd and flat.good texture in all edges.
8) Disintegration test
Film of 2*2 cm sq size is taken and disintegration is checked visually .
9) Calibration curve of Gingerol in Methanol
The data of absorbances and the calibration curve of Gingerol was found to be linear in the concentration range of 2-10 µg/ml having coefficient of regression value R² = 0.9986 , slope y = 0.8284x + 0.0202. The calibration curve of Gingerol.
Sr. No |
Concentration (µg/ml) |
Absorbance (nm) |
1 |
0.1 |
0.1019 |
2 |
0.2 |
0.1911 |
3 |
0.3 |
0.2614 |
4 |
0.4 |
0.3549 |
5 |
0.5 |
0.4342 |
Graph
CONCLUSION
The oral dissolving film was successfully formulated and evaluated on trial and error basis.Based on research study and result observed , prepared oral dissolving film provides less side effect .The natural drug is available easily ,and it is economic.The film use in migraine condtion ,it gives fast effect than other tablet ,capsule . The formulation rapidly acting & is innovative drug delivery system .It gives fast onset of action ,improved patient compliance, and ease for administration, better therapeutic effect .Natural drug use is not hamful to our body than synthetic drug .It is safer to use .Ginger is an anti -migraine drug ,HPMC,Citric acid, Polyethyelene glycol,Sucrose,Amranth are use ingredient in formulation.People now - a- days are high approach towards the herbal industry.
REFERENCES
Sakshi Gawas*, Rahul Bane, Aditya Patil, Madhura Khanolkar, Suchita Pednekar, Manasvi Sawant, Vijay Jagtap, Preparation and Evaluation the Extract from Herbal Source for Pathological Condition- Migraine, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 1960-1978. https://doi.org/10.5281/zenodo.15632189